Cell Robotics' infant heelstick test on the horizon:
This article was originally published in Clinica
Cell Robotics International plans to introduce its infant lasette healstick for drawing capillary blood from infant's heels later this year. The device, a modification of the firm's lasette finger perforator, vaporises the heel skin in a pinpoint manner. This avoids problems associated with existing blood collection methods, such as excessive puncture depth and contamination of the blood sample with wound debris, said the Albuquerque, New Mexico firm, which plans to submit an FDA 510(k) application by October 2002.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.